Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Thoracic 1Lymphoid 1Genitourinary 1

Conditions

Brain Neoplasms 487Glioma 228Glioblastoma 225Neoplasms 62Neuroblastoma 56Central Nervous System Neoplasms 56Breast Neoplasms 54Meningioma 48Astrocytoma 43Neuroma, Acoustic 38Spinal Cord Neoplasms 35Neurofibromatosis 1 32Sarcoma 29Oligodendroglioma 29Lung Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 27Neoplasm Metastasis 26Head and Neck Neoplasms 25Melanoma 22Lymphoma, Non-Hodgkin 22Leukemia 22Meningeal Carcinomatosis 21Medulloblastoma 21Hodgkin Disease 21Burkitt Lymphoma 20Testicular Neoplasms 19Lymphoma, Follicular 19Multiple Myeloma 18Gliosarcoma 18

Interventions

Magnetic Resonance Imaging 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Cerebrovascular Disorders × CNS × Clear all
NCT05287750 2022-03-18

Brain Diseases on 7.0T Magnetic Resonance Imaging

Chinese PLA General Hospital

Phase NA Recruiting
200 enrolled
CNS

Brain Neoplasms, Cerebrovascular Disorders

NCT02878707 2020-09-22

The Neuroprotective Effects of Dexmedetomidine During Brain Surgery

National Taiwan University Hospital

Phase NA Completed
160 enrolled
CNS

Brain Neoplasms, Cerebrovascular Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡